Stockreport

China authorities accept BeiGene application for expanded use of tislelizumab [Seeking Alpha]

BeiGene, Ltd. - American Depositary Shares  (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
PDF China's National Medical Products Administration has accepted for review BeiGene's (NASDAQ:BGNETislelizumab was recently approved there for urothelial cancer, its first [Read more]